Improvement in the outcome of invasive fusariosis in the last decade
Year: 2013
Type: article
Study design: Observational Study
Authors: M. Nucci, K.A. Marr, M.J.G.T. Vehreschild, C.A. de Souza, E. Velasco, P. Cappellano, F. Carlesse, F. Queiroz-Telles, D.C. Sheppard, A. Kindo, S. Cesaro, N. Hamerschlak, C. Solza, W.J. Heinz, M. Schaller, A. Atalla, S. Arikan-Akdagli, H. Bertz, C. Galvão Castro, R. Herbrecht, M. Hoenigl, G. Härter, N.E.U. Hermansen, A. Josting, L. Pagano, M.J.C. Salles, S.B. Mossad, D. Ogunc, A.C. Pasqualotto, V. Araujo, P.F. Troke, O. Lortholary, O.A. Comely, E. Anaissie
Institutions: Universidade Federal do Rio de Janeiro, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, University Hospital Cologne, Universidade Estadual de Campinas (UNICAMP), Instituto Nacional de Câncer - INCA, Universidade Federal de São Paulo, Support group for adolescents and children with cancer, Universidade Federal do Paraná, McGill University, Sri Ramachandra Institute of Higher Education and Research, Universidade do Estado do Rio de Janeiro, Universitätsklinikum Würzburg, Universitätsklinikum Tübingen, Universidade Federal de Juiz de Fora, Hacettepe University, University Medical Center Freiburg, Hôpital d'Hautepierre, Medical University of Graz, Copenhagen University Hospital, Rigshospitalet, Università Cattolica del Sacro Cuore, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Akdeniz University, Universidade Federal de Ciências da Saúde de Porto Alegre, Governador Celso Ramos Hospital, Institut Pasteur, University of Cologne, University of Cincinnati
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Pfizer, Astellas Pharma
OpenAlex ID: W1908365728